Publications
5600 Results
- Journal / Conference
- New England Journal of Medicine Mar 28;380(13):1226-1234
- Year
- 2019
- Research Committee(s)
- Breast
- PMID
- PMID30917258
- PMC
- PMC6885383
- Study Number(s)
- S0226
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer
- Journal / Conference
- Journal for ImmunoTherapy of Cancer Apr 10;7(1):88
- Year
- 2019
- Research Committee(s)
- Breast
- PMID
- PMID30967156
- PMC
- PMC6457012
- Study Number(s)
- S0800
Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trial
- Journal / Conference
- Journal of Clinical Oncology Jul 20;37(21):1790-1799
- Year
- 2019
- Research Committee(s)
- Lymphoma
- PMID
- PMID30939090
- PMC
- PMC6774813
Dose-Adjusted EPOCH-R Compared with R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase 3 Intergroup Trial Alliance/CALGB 50303
- Journal / Conference
- J Clin Oncol 37, 2019 (suppl; abstr 552); ASCO Annual Meeting (May 31-June 4, 2019, Chicago, IL), poster session
- Year
- 2019
- Research Committee(s)
- Breast
- Study Number(s)
- S0307
Factors associated with osteonecrosis of the jaw in women with breast cancer receiving highdose bisphosphonates to prevent breast cancer metastases as part of the SWOG 0307 trial
- Journal / Conference
- J Clin Oncol 37 (suppl; abstr 11502);ASCO Annual Meeting (May 31-June 4, 2019, Chicago, IL), oral
- Year
- 2019
- Research Committee(s)
- Symptom Management and Survivorship
- Study Number(s)
- S0702
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases: SWOG S0702, NCT00874211
- Journal / Conference
- J Clin Oncol 37, 2019 (suppl; abstr 552); ASCO Annual Meeting (May 31-June 4, 2019, Chicago, IL), poster session
- Year
- 2019
- Research Committee(s)
- Lung
- Study Number(s)
- S1206 (8811)
S1206: A Dose-Finding Study followed by a Phase II Randomized, Placebo-Controlled Trial of Chemoradiotherapy (CRT) with or without Veliparib in Stage III Non-Small Cell Lung Cancer (NSCLC)
- Journal / Conference
- J Clin Oncol 37(suppl; abstr 4506); ASCO Annual Meeting (May 31-June 4, 2019, Chicago, IL), oral
- Year
- 2019
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1314
SWOG S1314: A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer
- Journal / Conference
- J Clin Oncol 37(suppl; abstr 6516); American Society of Clinical Oncology (5/31/2019 - 6/4/2019, Chicago IL), oral
- Year
- 2019
- Research Committee(s)
- Cancer Care Delivery
- Study Number(s)
- S1105
Randomized Trial of Text-Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women with Early Stage Breast Cancer: SWOG S1105, NCT01515800
- Journal / Conference
- J Clin Oncol 37(suppl; abstr 9022); ASCO (5/31/2019-6/4/2019, Chicago IL), poster discussion
- Year
- 2019
- Research Committee(s)
- Lung
- Study Number(s)
- S1400G
A Phase II Study of Talazoparib (BMN 673) in Patients with Homologous Recombination Repair Deficiency (HRRD) Positive Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub- Study, S1400G)
- Journal / Conference
- J Clin Oncol 37(suppl; abstr 9075); American Society of Clinical Oncology (5/31/19-6/4/19, Chicago IL), poster session
- Year
- 2019
- Research Committee(s)
- Lung
- Study Number(s)
- S1400K